Global Ovarian Cancer Drugs Market Research Report 2016

January 2017 | 102 pages | ID: GAE9B36E657EN
QYResearch

Abstracts

Notes:

Production, means the output of Ovarian Cancer Drugs

Revenue, means the sales value of Ovarian Cancer Drugs

This report studies Ovarian Cancer Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Roche
• Boehringer Ingelheim
• Celgene
• Amgen
• AstraZeneca
• GlaxoSmithKline

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Ovarian Cancer Drugs in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Oral Therapy
• Injectable Therapy

Split by application, this report focuses on consumption, market share and growth rate of Ovarian Cancer Drugs in each application, can be divided into

• Chemotherapy
• Targeted Therapy
• Immunotherapy (Biologic Therapy)
• Others

Contents

Global Ovarian Cancer Drugs Market Research Report 2016

1 OVARIAN CANCER DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Ovarian Cancer Drugs
1.2 Ovarian Cancer Drugs Segment by Type
  1.2.1 Global Production Market Share of Ovarian Cancer Drugs by Type in 2015
  1.2.2 Oral Therapy
  1.2.3 Injectable Therapy
1.3 Ovarian Cancer Drugs Segment by Application
  1.3.1 Ovarian Cancer Drugs Consumption Market Share by Application in 2015
  1.3.2 Chemotherapy
  1.3.3 Targeted Therapy
  1.3.4 Immunotherapy (Biologic Therapy)
  1.3.5 Others
1.4 Ovarian Cancer Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Status and Prospect (2011-2021)
  1.4.6 Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Ovarian Cancer Drugs (2011-2021)

2 GLOBAL OVARIAN CANCER DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Ovarian Cancer Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 Global Ovarian Cancer Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Ovarian Cancer Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Ovarian Cancer Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Ovarian Cancer Drugs Market Competitive Situation and Trends
  2.5.1 Ovarian Cancer Drugs Market Concentration Rate
  2.5.2 Ovarian Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL OVARIAN CANCER DRUGS CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Ovarian Cancer Drugs Capacity and Market Share by Region (2011-2016)
3.2 Global Ovarian Cancer Drugs Production and Market Share by Region (2011-2016)
3.3 Global Ovarian Cancer Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.10 Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL OVARIAN CANCER DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Ovarian Cancer Drugs Consumption by Regions (2011-2016)
4.2 North America Ovarian Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Ovarian Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Ovarian Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Ovarian Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Ovarian Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 Ovarian Cancer Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL OVARIAN CANCER DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Ovarian Cancer Drugs Production and Market Share by Type (2011-2016)
5.2 Global Ovarian Cancer Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Ovarian Cancer Drugs Price by Type (2011-2016)
5.4 Global Ovarian Cancer Drugs Production Growth by Type (2011-2016)

6 GLOBAL OVARIAN CANCER DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Ovarian Cancer Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Ovarian Cancer Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL OVARIAN CANCER DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Roche
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Ovarian Cancer Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Roche Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Boehringer Ingelheim
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Ovarian Cancer Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Boehringer Ingelheim Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Celgene
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Ovarian Cancer Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Celgene Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Amgen
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Ovarian Cancer Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Amgen Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 AstraZeneca
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Ovarian Cancer Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 AstraZeneca Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 GlaxoSmithKline
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Ovarian Cancer Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 GlaxoSmithKline Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview

8 OVARIAN CANCER DRUGS MANUFACTURING COST ANALYSIS

8.1 Ovarian Cancer Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Ovarian Cancer Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Ovarian Cancer Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Ovarian Cancer Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL OVARIAN CANCER DRUGS MARKET FORECAST (2016-2021)

12.1 Global Ovarian Cancer Drugs Capacity, Production, Revenue Forecast (2016-2021)
12.2 Global Ovarian Cancer Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Ovarian Cancer Drugs Production Forecast by Type (2016-2021)
12.4 Global Ovarian Cancer Drugs Consumption Forecast by Application (2016-2021)
12.5 Ovarian Cancer Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Ovarian Cancer Drugs
Figure Global Production Market Share of Ovarian Cancer Drugs by Type in 2015
Figure Product Picture of Oral Therapy
Table Major Manufacturers of Oral Therapy
Figure Product Picture of Injectable Therapy
Table Major Manufacturers of Injectable Therapy
Table Ovarian Cancer Drugs Consumption Market Share by Application in 2015
Figure Chemotherapy Examples
Figure Targeted Therapy Examples
Figure Immunotherapy (Biologic Therapy) Examples
Figure Others Examples
Figure North America Ovarian Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Ovarian Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Ovarian Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Ovarian Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Ovarian Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Ovarian Cancer Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Ovarian Cancer Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Ovarian Cancer Drugs Capacity of Key Manufacturers (2015 and 2016)
Table Global Ovarian Cancer Drugs Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Ovarian Cancer Drugs Capacity of Key Manufacturers in 2015
Figure Global Ovarian Cancer Drugs Capacity of Key Manufacturers in 2016
Table Global Ovarian Cancer Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Ovarian Cancer Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Ovarian Cancer Drugs Production Share by Manufacturers
Figure 2016 Ovarian Cancer Drugs Production Share by Manufacturers
Table Global Ovarian Cancer Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Ovarian Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Ovarian Cancer Drugs Revenue Share by Manufacturers
Table 2016 Global Ovarian Cancer Drugs Revenue Share by Manufacturers
Table Global Market Ovarian Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Ovarian Cancer Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Ovarian Cancer Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Ovarian Cancer Drugs Product Type
Figure Ovarian Cancer Drugs Market Share of Top 3 Manufacturers
Figure Ovarian Cancer Drugs Market Share of Top 5 Manufacturers
Table Global Ovarian Cancer Drugs Capacity by Regions (2011-2016)
Figure Global Ovarian Cancer Drugs Capacity Market Share by Regions (2011-2016)
Figure Global Ovarian Cancer Drugs Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Ovarian Cancer Drugs Capacity Market Share by Regions
Table Global Ovarian Cancer Drugs Production by Regions (2011-2016)
Figure Global Ovarian Cancer Drugs Production and Market Share by Regions (2011-2016)
Figure Global Ovarian Cancer Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Ovarian Cancer Drugs Production Market Share by Regions
Table Global Ovarian Cancer Drugs Revenue by Regions (2011-2016)
Table Global Ovarian Cancer Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Ovarian Cancer Drugs Revenue Market Share by Regions
Table Global Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Ovarian Cancer Drugs Consumption Market by Regions (2011-2016)
Table Global Ovarian Cancer Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Ovarian Cancer Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Ovarian Cancer Drugs Consumption Market Share by Regions
Table North America Ovarian Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Ovarian Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table China Ovarian Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Ovarian Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Ovarian Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Ovarian Cancer Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Ovarian Cancer Drugs Production by Type (2011-2016)
Table Global Ovarian Cancer Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Ovarian Cancer Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Ovarian Cancer Drugs by Type
Table Global Ovarian Cancer Drugs Revenue by Type (2011-2016)
Table Global Ovarian Cancer Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Ovarian Cancer Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Ovarian Cancer Drugs by Type
Table Global Ovarian Cancer Drugs Price by Type (2011-2016)
Figure Global Ovarian Cancer Drugs Production Growth by Type (2011-2016)
Table Global Ovarian Cancer Drugs Consumption by Application (2011-2016)
Table Global Ovarian Cancer Drugs Consumption Market Share by Application (2011-2016)
Figure Global Ovarian Cancer Drugs Consumption Market Share by Application in 2015
Table Global Ovarian Cancer Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Ovarian Cancer Drugs Consumption Growth Rate by Application (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Ovarian Cancer Drugs Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Ovarian Cancer Drugs Market Share (2011-2016)
Table Celgene Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Ovarian Cancer Drugs Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Ovarian Cancer Drugs Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Ovarian Cancer Drugs Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Ovarian Cancer Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Ovarian Cancer Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ovarian Cancer Drugs
Figure Manufacturing Process Analysis of Ovarian Cancer Drugs
Figure Ovarian Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Ovarian Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Ovarian Cancer Drugs
Table Distributors/Traders List
Figure Global Ovarian Cancer Drugs Capacity, Production and Growth Rate Forecast (2016-2021)
Figure Global Ovarian Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Ovarian Cancer Drugs Production Forecast by Regions (2016-2021)
Table Global Ovarian Cancer Drugs Consumption Forecast by Regions (2016-2021)
Table Global Ovarian Cancer Drugs Production Forecast by Type (2016-2021)
Table Global Ovarian Cancer Drugs Consumption Forecast by Application (2016-2021)